accur
quantif
impur
exist
separ
crystallin
phase
trace
level
drug
materi
import
issu
pharmaceut
industri
present
studi
thermoanalyt
approach
previous
develop
quantifi
trace
level
polymorph
impur
form
ii
metast
nuclei
commerci
salmeterol
xinafo
powder
success
appli
slight
modif
ribavirin
antivir
drug
exhibit
roughli
similar
polymorphdepend
crystal
kinet
melt
salmeterol
xinafo
essenti
approach
involv
model
crystal
kinet
test
refer
drug
materi
melt
use
avramierofeev
ae
rate
express
deriv
mathemat
equat
relat
ae
kinet
constant
composit
refer
polymorph
mixtur
use
deriv
equat
form
calibr
curv
calcul
impur
content
test
sampl
comput
ae
constant
ribavirin
modif
latter
equat
incorpor
empir
expon
found
necessari
account
compositiondepend
chang
crystal
kinet
refer
mixtur
modif
made
possibl
determin
polymorph
impur
content
low
ww
ribavirin
sampl
induc
differ
form
grind
treatment
polymorph
import
solidst
properti
consider
formul
develop
largescal
product
solid
dosag
form
pharmaceut
industri
sinc
differ
crystallin
see
front
matter
elsevi
bv
right
reserv
polymorph
exhibit
differ
physicochem
properti
eg
melt
point
densiti
hard
stabil
dissolut
rate
possibl
bioavail
stringent
regulatori
requir
impos
identif
specif
polymorph
particular
drug
materi
part
qualiti
assur
process
stabil
reason
form
stabl
ambient
condit
normal
employ
drug
formul
contamin
drug
materi
altern
metast
polymorph
form
occur
crystal
grindingmil
form
mechan
treatment
particular
concern
sinc
polymorph
impur
could
advers
compromis
stabil
perform
final
product
order
limit
undesir
physic
impur
pharmaceut
materi
accur
quantif
trace
level
impur
exist
separ
crystallin
phase
becom
import
issu
howev
wide
use
method
solidphas
character
differenti
scan
calorimetri
dsc
powder
xray
diffract
pxrd
fouriertransform
infrar
ftir
spectroscopi
nearinfrar
nir
spectroscopi
normal
suffici
sensit
detect
rel
low
level
polymorph
impur
previou
studi
thermoanalyt
approach
use
standard
dsc
instrument
success
appli
quantifi
trace
level
polymorph
form
ii
impur
form
sampl
salmeterol
xinafo
sx
tong
et
al
essenti
approach
involv
measur
recrystal
rate
form
ii
form
melt
dsc
vari
scan
speed
analysi
data
express
curv
nonlinear
iter
fit
avramierofeev
ae
equat
test
sx
sampl
refer
materi
form
ii
mix
variou
defin
ratio
mathemat
equat
base
instantan
nucleat
model
deriv
specif
relat
ae
rate
constant
determin
use
physic
mixtur
refer
sx
materi
correspond
crystal
phase
composit
ie
construct
calibr
curv
equat
use
calcul
concentr
polymorph
form
ii
impur
test
form
sampl
comput
ae
rate
constant
note
principl
techniqu
base
direct
measur
enthalpi
fusion
estim
actual
amount
form
ii
present
standard
dsc
approach
rather
fast
highmelt
polymorph
gener
form
melt
demonstr
quantif
low
ww
form
ii
feasibl
also
suggest
techniqu
could
potenti
appli
enantiotrop
polymorph
pair
order
verifi
gener
applic
develop
approach
enantiotrop
polymorph
system
refin
approach
adapt
variant
crystal
kinet
extend
work
ribavirin
antivir
drug
display
roughli
similar
polymorphdepend
crystal
kinet
melt
salmeterol
xinafo
ribavirin
long
known
exist
two
enantiotrop
relat
polymorph
form
ii
see
section
witkowski
et
al
prusin
sundaralingam
form
ii
stabl
form
ambient
temperatur
melt
c
form
metast
polymorph
melt
c
witkowski
et
al
drug
wide
use
sever
decad
treat
viral
infect
hepat
c
bacon
recent
receiv
renew
interest
due
emerg
role
treatment
sever
acut
respiratori
syndrom
sar
tsang
et
al
lee
et
al
hon
et
al
present
studi
ribavirin
pure
form
ii
refer
materi
first
prepar
respect
transit
temperatur
recrystal
pharmaceut
grade
ribavirin
form
ii
solut
melt
confirm
ident
polymorph
dsc
pxrd
ftir
spectroscopi
recrystal
refer
pharmaceut
grade
ribavirin
sampl
subject
thermal
analysi
report
salmeterol
xinafo
order
gener
appropri
level
ie
ww
form
metast
phase
pharmaceut
grade
ribavirin
trial
determin
establish
approach
materi
tritur
manual
ground
use
selffabr
ball
mill
system
variou
time
period
note
grind
treatment
might
also
produc
amorph
materi
dsc
analysi
ground
ribavirin
sampl
reveal
recrystal
exotherm
melt
form
ii
even
slowest
scan
rate
k
min
pxrd
show
neglig
chang
diffract
pattern
data
shown
suggest
amorph
ribavirin
either
absent
present
trace
nondetect
quantiti
low
level
amorph
microdomain
sampl
unlik
signific
bear
polymorph
impur
determin
approach
measur
impur
term
recrystal
rate
form
form
ii
melt
strictli
depend
amount
form
nuclei
present
see
section
ribavirin
raw
materi
rrw
usp
grade
purchas
intern
laboratori
ltd
la
vega
usa
absolut
ethanol
suppli
merck
germani
potassium
dihydrogen
phosphat
analyt
grade
methanol
hplc
grade
obtain
respect
riedeld
haen
co
ltd
germani
tedia
co
inc
usa
water
use
deioniz
doubl
distil
crystal
structur
rrw
consist
form
ii
report
literatur
witkowski
et
al
prusin
sundaralingam
pure
ribavirin
form
ii
rii
crystal
prepar
recrystal
rrw
water
prusin
sundaralingam
slight
excess
rrw
dissolv
water
c
form
supersatur
solut
solut
left
cool
slowli
room
temperatur
result
crystal
rii
harvest
dri
thoroughli
desicc
phosphor
pentoxid
prior
use
pure
ribavirin
form
ri
crystal
prepar
recrystal
rrw
melt
c
hotstag
microscop
hsm
crystal
form
result
materi
confirm
dsc
pxrd
ftir
spectroscopi
physic
mixtur
rii
ri
prepar
gentl
blend
use
geometr
dilut
techniqu
rii
alon
also
subject
mix
treatment
check
possibl
induct
metast
form
nuclei
signific
chang
thermal
behavior
materi
observ
rrw
place
porcelain
mortar
tritur
manual
use
pestl
extemporan
compound
chan
et
al
sampl
remov
dsc
analysi
min
sinc
handtritur
ribavirin
sampl
subject
variabl
associ
inconsist
appli
shear
stress
anoth
set
data
obtain
parallel
comparison
use
selffabr
ball
mill
system
three
lead
sphere
cm
diamet
place
insid
cylindr
metal
contain
id
cm
height
cm
contain
rotat
longitudin
axi
constant
speed
rpm
sampl
withdrawn
analysi
variou
time
interv
tga
perform
open
pan
use
perkinelm
thermogravimetr
analyz
tga
thermal
analysi
control
tac
approxim
mg
sampl
accur
weigh
place
pan
scan
c
min
c
dsc
analysi
perform
use
perkinelm
pyri
differenti
scan
calorimet
pyri
manag
softwar
indium
c
h
f
j
g
use
calibr
accur
weigh
sampl
mg
place
hermet
seal
aluminum
pan
scan
c
min
nitrogen
purg
sampl
examin
hotstag
microscop
leica
galen
iii
melt
recrystal
event
heat
rate
set
c
min
spectra
record
kbr
disk
use
perkinelm
fouriertransform
infrar
red
system
spectrumbx
perkinelm
beaconsfield
buckinghamshir
uk
number
scan
resolut
cm
sampl
scan
cm
interv
cm
pxrd
pattern
ribavirin
ri
rii
sampl
record
philip
powder
xray
diffract
system
model
pw
kw
use
cu
anod
interv
step
size
count
time
ribavirin
assay
use
stabilityind
hplc
method
report
shah
et
al
slight
modif
chan
et
al
analysi
employ
hypersil
revers
phase
column
mm
mm
id
thermo
hypersil
ltd
cheshir
uk
water
lc
system
equip
water
photodiod
array
detector
autosampl
water
usa
mobil
phase
compos
potassium
dihydrogen
phosphat
solut
pure
methanol
vv
elut
isocrat
flow
rate
ml
min
detector
respons
set
nm
ribavirin
elut
singl
peak
chromatogram
around
min
rrw
rii
ri
sampl
dissolv
water
yield
final
concentr
mg
ml
fifti
microlitr
sampl
inject
onto
column
calibr
curv
construct
use
standard
ribavirin
solut
within
appropri
concentr
rang
display
excel
linear
r
larger
measur
perform
triplic
sigmastat
systat
softwar
inc
spss
hong
kong
ltd
employ
nonlinear
regress
analysi
studi
ribavirin
form
ii
crystal
rrw
rii
rodshap
wherea
form
crystal
ri
distinctli
differ
platelet
examin
optic
light
microscopi
fig
depict
dsc
tga
curv
rrw
obtain
c
min
fig
show
dsc
profil
rrw
rii
ri
gener
c
min
reveal
fig
rrw
melt
c
partial
recrystal
form
subsequ
melt
c
thermal
behavior
close
agreement
report
literatur
witkowski
et
al
thermal
degrad
evid
tga
k
min
temperatur
reach
c
rrw
rii
melt
around
c
melt
endotherm
form
virtual
discern
fig
comparison
fusion
thermodynam
properti
ri
form
rii
form
ii
show
form
lower
enthalpi
fusion
h
f
form
ii
j
g
versu
j
g
higher
melt
point
form
ii
c
versu
c
consist
enantiotrop
polymorph
burger
ramberg
b
dsc
profil
individu
ri
rii
sampl
devoid
melt
endotherm
altern
polymorph
form
reflect
high
level
polymorph
puriti
recrystal
sampl
fig
polymorph
ident
variou
ribavirin
sampl
confirm
ftir
spectroscopi
fig
pxrd
fig
suggest
differencessimilar
ftir
spectra
pxrd
pattern
among
sampl
rii
ri
distinctli
differ
polymorph
rrw
rii
essenti
form
care
examin
wavenumb
select
band
spectra
reveal
signific
differ
intermolecular
intramolecular
hydrogen
bond
network
rii
ri
tabl
consist
structur
differ
expect
two
polymorph
comparison
observ
pxrd
pattern
simul
crystal
structur
data
allen
bruno
et
al
also
confirm
rii
ri
stabl
form
ii
metast
form
respect
report
literatur
prusin
sundaralingam
interestingli
report
crystal
densiti
form
ii
g
cm
lower
form
g
cm
prusin
sundaralingam
appear
violat
densiti
rule
burger
ramberg
nonetheless
pharmaceut
exampl
densiti
rule
hold
chloroprocain
schmidt
griesser
hydroquinon
neotam
dong
et
al
resorcinol
ribavirin
content
rrw
rii
ri
determin
hplc
respect
attest
high
chemic
purityintegr
sampl
furthermor
addit
peak
due
potenti
degrad
product
could
observ
hplc
chromatogram
ribavirin
sampl
take
dsc
ftir
pxrd
hplc
data
togeth
consider
appar
rii
ri
sampl
chemic
polymorph
pure
therefor
use
refer
standard
subsequ
quantit
analysi
dsc
scan
includ
physic
mixtur
rii
ri
rrw
sampl
tritur
variou
time
period
recrystal
form
assum
occur
onset
melt
form
ii
form
polymorph
convers
melt
point
form
observ
even
lowest
scan
speed
use
ie
c
min
probabl
presenc
high
activ
energi
barrier
solidsolid
polymorph
convers
thu
time
allow
recrystal
calcul
scan
speed
temperatur
differ
onset
first
second
melt
endotherm
h
f
second
peak
melt
endotherm
form
obtain
scan
speed
ribavirin
sampl
normal
refer
ri
sampl
measur
scan
speed
yield
fraction
materi
recrystal
observ
h
f
second
melt
endotherm
increas
increas
time
tritur
fig
curv
polymorph
mixtur
ribavirin
contain
differ
weight
percentag
ri
crystal
present
fig
curv
polymorph
mixtur
ie
rii
mix
vari
weight
percentag
ri
crystal
rrw
sampl
tritur
manual
use
selffabr
ball
mill
differ
time
period
fit
avrami
equat
michaelsen
dahm
model
consid
crystal
reaction
occur
via
process
nucleat
growth
crystal
time
fraction
recrystal
materi
k
crystal
rate
constant
n
model
expon
typic
integ
repres
dimension
order
nucleat
growth
process
note
avrami
equat
differ
avramierofeev
equat
inclus
exponenti
term
rate
constant
ie
k
k
n
k
rate
constant
ae
equat
previou
studi
employ
ae
model
polymorph
puriti
determin
salmeterol
xinafo
show
expon
n
assum
valu
correspond
observ
twodimension
platelet
morpholog
crystal
tong
et
al
similarli
ribavirin
recrystal
platelet
melt
data
fit
could
also
perform
n
valu
fix
shown
tabl
good
fit
reveal
high
r
observ
data
except
sampl
contain
higher
concentr
metast
form
produc
ball
mill
techniqu
reason
poor
fit
data
latter
sampl
remain
obscur
may
due
chang
nucleat
mechan
mill
time
salmeterol
xinafo
recrystal
ribavirin
melt
could
assum
follow
instantan
nucleat
model
kashchiev
lead
follow
deriv
equat
tong
et
al
x
weight
fraction
metast
nuclei
materi
matrix
c
c
constant
relat
homogen
heterogen
nucleat
melt
respect
c
typic
much
larger
c
ie
heterogen
nucleat
domin
shown
case
salmeterol
xinafo
equat
hold
r
tong
et
al
howev
ribavirin
relationship
appar
linear
function
accord
equat
fig
highlight
complex
potenti
limit
make
prior
assumpt
recri
talliz
kinet
differ
melt
analyz
dsc
appar
nonlinear
would
impli
chang
twodimension
crystal
kinet
rii
sampl
mix
increas
proport
ri
crystal
fundament
reason
variat
outsid
scope
work
account
observ
nonlinearitykinet
chang
equat
empir
modifi
inclus
expon
follow
calibr
curv
best
fit
ribavirin
r
obtain
c
c
tabl
paramet
curv
fit
avrami
equat
n
fix
togeth
estim
weight
percentag
metast
polymorph
gener
handtritur
ballmil
rrw
sampl
differ
time
interv
construct
calibr
curv
base
equat
quantiti
ribavirin
metast
form
nuclei
ww
gener
grind
rrw
sampl
variou
time
period
quantifi
fig
show
effect
manual
tritur
ball
mill
amount
metast
polymorph
produc
function
time
grind
techniqu
afford
increas
amount
metast
form
increas
grind
time
seen
tabl
trace
quantiti
metast
phase
low
ww
gener
ribavirin
rrw
sampl
manual
tritur
ball
mill
readili
determin
thermoanalyt
approach
previous
establish
quantifi
trace
level
polymorph
impur
commerci
salmeterol
xinafo
sampl
success
appli
slight
modif
enantiotrop
polymorph
pair
ribavirin
present
studi
modif
involv
incorpor
empir
expon
deriv
calibr
equat
equat
account
observ
compositiondepend
chang
crystal
kinet
refer
polymorph
mixtur
modif
made
possibl
determin
low
ww
metast
polymorph
ribavirin
form
ii
sampl
induc
differ
form
grind
treatment
rel
insensit
prior
assumpt
made
crystal
kinet
materi
studi
modifi
approach
may
find
wide
applic
qualiti
control
enantiotrop
relat
drug
polymorph
